Fresenius Kabi and Phlow Corp. have announced a collaboration to onshore the manufacture of Epinephrine Injection, USP, a medicine designated as essential by the U.S. Food and Drug Administration and the World Health Organization. The agreement covers domestic production of
WuXi Biologics said it has received a Platinum Medal from EcoVadis for the third year in a row, marking the highest level of recognition from the sustainability assessment platform. The rating places the company among the top one percent of
Samsung Biologics said its product carbon footprint system has been validated by Det Norske Veritas, an independent third-party assurance provider. The validation confirms that the company’s PCF calculation methodology aligns with globally recognized standards, including ISO 14067 and PAS 2050.
Scarab Genomics said it has entered into an exclusive licensing partnership with Bionova Scientific, granting Bionova rights to use one of Scarab’s proprietary Clean Genome® E. coli strains for plasmid DNA production. The agreement supports pDNA manufacturing for advanced biologics
Eurofins CDMO Alphora said its Canadian-based division is receiving advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program to support a research and development collaboration focused on next-generation antibody-drug conjugate production. The project aims
OXB said it has expanded its strategic partnership with Bristol Myers Squibb through a new Commercial Supply Agreement covering the manufacture and supply of lentiviral vectors for CAR-T programs. The agreement builds on an existing relationship between the companies that
Charles River Laboratories said it will close its cell therapy contract development and manufacturing site in Hanover, Maryland, resulting in the elimination of 20 positions. The closure was disclosed in a state Worker Adjustment and Retraining Notification filing. The decision
Thermo Fisher Scientific said it will close a manufacturing facility in Franklin, Massachusetts, and eliminate up to 80 positions as part of an ongoing effort to adjust its manufacturing footprint. The decision was disclosed in an updated state Worker Adjustment
Naresta, one of Lithuania’s largest construction companies, has completed a new logistics centre for the Stem Cell Research Center, a company within the Northway group and the Northway Biotech cluster. The project was delivered in nine months and represents the
BioDlink has announced the successful go-live of Veeva QMS, marking a milestone in the company’s quality digitalization strategy. The system entered operation following a launch event on January 29 attended by representatives from Veeva and the joint project team. The
